grants_govPAR-27-111
Open
Biological Testing Facility for Contraception & Reproductive Health (X01 Clinical Trial Not Allowed)
- Response deadline
- May 7, 2029 Due in 995 days
- Date posted
- Jun 1, 2026
- Source
- Open notice
Description
The purpose of this notice of funding opportunity (NOFO) is to provide investigators with a mechanism to request services from the state-of-the-art Biological Testing Facility that would advance their contraceptive development or reproductive health programs. This NOFO aims to position innovative and validated methods for future regulatory submission and/or clinical development. Applicants do not need to have current NIH funding to apply, but priority may be given to programs receiving NIH support at the time of application submission.
Classifications
- NAICS93.865
Documents (1)
- DownloadPAR-27-111-Full-Announcement.htmltext/html;charset=UTF-8111 KB
Contacts
Similar contracts
- Novel Experiential Technologies Assisting Individual Learning (NExT AI) Hubs (P20 Clinical Trial Optional)Due Oct 2, 2026
- Limited Competition: Intellectual and Developmental Disabilities Research Centers 2027 (P50 Clinical Trial Optional)Due Oct 2, 2026
- Early Immune System Development and Ontogeny (R01 Clinical Trial Optional)Due Nov 5, 2028
- Leveraging Network Infrastructure to Conduct Innovative Research for Women, Children, Pregnant and Lactating Women, and Persons with Disabilities (UG3/UH3 - Clinical Trial Optional)Due Nov 15, 2027
- Innovative Screening Approaches and Therapies for Screenable Disorders in Newborns (R01 - Clinical Trial Optional)Due Nov 16, 2027
- Innovative Screening Approaches and Therapies for Screenable Disorders in Newborns (R21 - Clinical Trial Optional)Due Nov 16, 2027